| Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models MJ McConnell, L Actis, J Pachón FEMS microbiology reviews 37 (2), 130-155, 2013 | 735 | 2013 |
| Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic Features JM Cisneros, MJ Reyes, J Pachon, B Becerril, FJ Caballero, ... Clinical infectious diseases 22 (6), 1026-1032, 1996 | 571 | 1996 |
| Severe community-acquired pneumonia J Pachon, MD Prados, F Capote, JA Cuello, J Garnacho, A Verano Am Rev Respir Dis 142 (369.373), 1990 | 490 | 1990 |
| Pyogenic, tuberculous, and brucellar vertebral osteomyelitis: a descriptive and comparative study of 219 cases JD Colmenero, ME Jimenez-Mejias, FJ Sanchez-Lora, JM Reguera, ... Annals of the rheumatic diseases 56 (12), 709-715, 1997 | 464 | 1997 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachón, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 360 | 2020 |
| Biofilm formation in Acinetobacter baumannii: associated features and clinical implications J Rodríguez‐Baño, S Marti, S Soto, F Fernández‐Cuenca, JM Cisneros, ... Clinical microbiology and infection 14 (3), 276-278, 2008 | 339 | 2008 |
| Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis LF López-Cortés, R Ruiz-Valderas, P Viciana, A Alarcón-González, ... Clinical pharmacokinetics 41, 681-690, 2002 | 315 | 2002 |
| Nosocomial outbreak of infection with pan–drug-resistant Acinetobacter baumannii in a tertiary care university hospital R Valencia, LA Arroyo, M Conde, JM Aldana, MJ Torres, ... Infection Control & Hospital Epidemiology 30 (3), 257-263, 2009 | 302 | 2009 |
| Role of Acinetobactin-Mediated Iron Acquisition Functions in the Interaction of Acinetobacter baumannii Strain ATCC 19606T with Human Lung Epithelial Cells … JA Gaddy, BA Arivett, MJ McConnell, R López-Rojas, J Pachón, LA Actis Infection and immunity 80 (3), 1015-1024, 2012 | 282 | 2012 |
| Optimizing the clinical use of vancomycin R Álvarez, LE López Cortés, J Molina, JM Cisneros, J Pachón Antimicrobial agents and chemotherapy 60 (5), 2601-2609, 2016 | 274 | 2016 |
| Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae A Olaya-Abril, R Prados-Rosales, MJ McConnell, R Martín-Peña, ... Journal of proteomics 106, 46-60, 2014 | 240 | 2014 |
| Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii C Rumbo, E Gato, M López, C Ruiz de Alegría, F Fernández-Cuenca, ... Antimicrobial agents and chemotherapy 57 (11), 5247-5257, 2013 | 240 | 2013 |
| Activity of Tigecycline (GAR-936) against Acinetobacter baumannii Strains, Including Those Resistant to Imipenem ME Pachón-Ibánez, ME Jiménez-Mejías, C Pichardo, AC Llanos, ... Antimicrobial agents and chemotherapy 48 (11), 4479-4481, 2004 | 240 | 2004 |
| Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii MJ McConnell, C Rumbo, G Bou, J Pachón Vaccine 29 (34), 5705-5710, 2011 | 239 | 2011 |
| Postoperative spondylodiskitis: etiology, clinical findings, prognosis, and comparison with nonoperative pyogenic spondylodiskitis ME Jiménez-Mejías, J de Dios Colmenero, FJ Sánchez-Lora, ... Clinical Infectious Diseases 29 (2), 339-345, 1999 | 238 | 1999 |
| Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals J Rodríguez-Baño, JM Cisneros, F Fernández-Cuenca, A Ribera, J Vila, ... Infection Control & Hospital Epidemiology 25 (10), 819-824, 2004 | 232 | 2004 |
| Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii Y Smani, A Fàbrega, I Roca, V Sánchez-Encinales, J Vila, J Pachón Antimicrobial agents and chemotherapy 58 (3), 1806-1808, 2014 | 227 | 2014 |
| Brucella Endocarditis: Clinical, Diagnostic, and Therapeutic Approach JM Reguera, A Alarcon, F Miralles, J Pachon, C Juarez, JD Colmenero European Journal of Clinical Microbiology and Infectious Diseases 22, 647-650, 2003 | 201 | 2003 |
| Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii R López-Rojas, J Domínguez-Herrera, MJ McConnell, F Docobo-Peréz, ... Journal of Infectious Diseases 203 (4), 545-548, 2011 | 182 | 2011 |
| Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study JM Cisneros, J Rodriguez-Bano, F Fernández-Cuenca, A Ribera, J Vila, ... Clinical microbiology and infection 11 (11), 874-879, 2005 | 180 | 2005 |
